Dissemin is shutting down on January 1st, 2025

Published in

Taylor and Francis Group, Statistics in Biopharmaceutical Research, 2(5), p. 142-155

DOI: 10.1080/19466315.2013.791483

Links

Tools

Export citation

Search in Google Scholar

Bayesian inference on risk differences: an application to multivariate meta-analysis of adverse events in clinical trials

Journal article published in 2013 by Yong Chen, Sheng Luo ORCID, Haitao Chu ORCID, Peng Wei
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Multivariate meta-analysis is useful in combining evidence from independent studies which involve several comparisons among groups based on a single outcome. For binary outcomes, the commonly used statistical models for multivariate meta-analysis are multivariate generalized linear mixed effects models which assume risks, after some transformation, follow a multivariate normal distribution with possible correlations. In this article, we consider an alternative model for multivariate meta-analysis where the risks are modeled by the multivariate beta distribution proposed by Sarmanov (1966). This model have several attractive features compared to the conventional multivariate generalized linear mixed effects models, including simplicity of likelihood function, no need to specify a link function, and has a closed-form expression of distribution functions for study-specific risk differences. We investigate the finite sample performance of this model by simulation studies and illustrate its use with an application to multivariate meta-analysis of adverse events of tricyclic antidepressants treatment in clinical trials.